- Home
- FGEN vs PMAX Comparison
FGEN vs PMAX Comparison
Compare FGEN & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- PMAX
- Stock Information
- Founded
- FGEN 1993
- PMAX 2019
- Country
- FGEN United States
- PMAX Hong Kong
- Employees
- FGEN N/A
- PMAX N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- PMAX
- Sector
- FGEN Health Care
- PMAX
- Exchange
- FGEN Nasdaq
- PMAX Nasdaq
- Market Cap
- FGEN 34.5M
- PMAX 32.0M
- IPO Year
- FGEN 2014
- PMAX 2024
- Fundamental
- Price
- FGEN $0.57
- PMAX $0.64
- Analyst Decision
- FGEN
- PMAX
- Analyst Count
- FGEN 0
- PMAX 0
- Target Price
- FGEN N/A
- PMAX N/A
- AVG Volume (30 Days)
- FGEN 1.7M
- PMAX 2.2M
- Earning Date
- FGEN 02-24-2025
- PMAX 02-11-2025
- Dividend Yield
- FGEN N/A
- PMAX N/A
- EPS Growth
- FGEN N/A
- PMAX N/A
- EPS
- FGEN N/A
- PMAX 0.04
- Revenue
- FGEN $180,015,000.00
- PMAX $5,970,263.00
- Revenue This Year
- FGEN $22.05
- PMAX N/A
- Revenue Next Year
- FGEN N/A
- PMAX N/A
- P/E Ratio
- FGEN N/A
- PMAX $14.90
- Revenue Growth
- FGEN 16.15
- PMAX 30.05
- 52 Week Low
- FGEN $0.18
- PMAX $0.62
- 52 Week High
- FGEN $2.93
- PMAX $4.70
- Technical
- Relative Strength Index (RSI)
- FGEN 57.36
- PMAX N/A
- Support Level
- FGEN $0.51
- PMAX N/A
- Resistance Level
- FGEN $0.76
- PMAX N/A
- Average True Range (ATR)
- FGEN 0.09
- PMAX 0.00
- MACD
- FGEN -0.00
- PMAX 0.00
- Stochastic Oscillator
- FGEN 33.26
- PMAX 0.00
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
About PMAX Powell Max Limited Class A Ordinary Shares
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. Key revenue is derived from Hong Kong.